BDP1 and ovarian serous adenocarcinoma: In Figure 2, we demonstrate that the TFIIIB subunit BDP1 is specifically decreased (p = 0.01) in serous ovarian cancer and we wanted to determine if this alteration is stage‐speciifc in serous ovarian cancer.